News

Opioid substitution treatment (OST) is a key evidence-based tool used to manage opioid dependence and improve related health and social consequences. Yet increasing reports of the diversion and misuse of the controlled drugs used in this treatment in Europe are a cause for concern.

This month, Portugal took over the rotating presidency of the Council of the EU with the motto ‘Time to deliver: a fair, green and digital recovery’.

Professionals, academics or experts from European Neighbourhood Policy (ENP) countries (1) will have an opportunity to participate in the European Drugs Winter and Summer Schools this year, thanks to 10 bursaries being offered through the EU4Monitoring Drugs (EU4MD

Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related toxicity and other harms, resulting in emergency presentations to hospital (1).

The emergence of new drug trafficking routes, the reduced availability of drug-related health services and the adaptation of drug treatment protocols during the COVID-19 pandemic are among the findings highlighted today in a new EMCDDA report:

Dear colleagues, At the start of this year, when we embarked on our 25 years of monitoring celebrations, we knew it was going to be a special 12 months. Little did we know then just how unusual and challenging the year would turn out to be…

The EMCDDA and Serbia signed a new Working Arrangement t

It was with great sadness that the EMCDDA learned of the passing of Richard Hartnoll on 8 December, following a long illness.

There are signs that a methamphetamine industry is taking hold in Afghanistan, according to a new report published today by the EU drugs agency (EMCDDA).